These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 17034644

  • 1. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
    Miranda-Novales G, Leaños-Miranda BE, Vilchis-Pérez M, Solórzano-Santos F.
    Ann Clin Microbiol Antimicrob; 2006 Oct 12; 5():25. PubMed ID: 17034644
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus.
    Uete T, Matsuo K.
    Jpn J Antibiot; 1995 Mar 12; 48(3):402-8. PubMed ID: 7752453
    [Abstract] [Full Text] [Related]

  • 7. Synergy of vancomycin plus cefazolin or cephalothin against methicillin-resistance Staphylococcus epidermidis.
    Siebert WT, Moreland N, Williams TW.
    J Infect Dis; 1979 Apr 12; 139(4):452-7. PubMed ID: 438546
    [Abstract] [Full Text] [Related]

  • 8. Effect of vancomycin and teicoplanin alone or in combination with fusidic acid or amikacin against methicillin-resistant staphylococci.
    Roussel-Delvallez M, Wallet F, Barbiery P, Courcol RJ.
    J Chemother; 1997 Feb 12; 9(1):5-8. PubMed ID: 9106011
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of azithromycin in combination with amikacin, ceftazidime, ciprofloxacin or imipenem against clinical isolates of Acinobacter baumannii.
    Fernández-Cuenca F, Martínez-Martínez L, Pascual A, Perea EJ.
    Chemotherapy; 2003 May 12; 49(1-2):24-6. PubMed ID: 12714805
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill.
    Hosgor-Limoncu M, Ermertcan S, Tasli H, Yurtman AN.
    West Indian Med J; 2008 Mar 12; 57(2):106-11. PubMed ID: 19565951
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin.
    Climo MW, Patron RL, Archer GL.
    Antimicrob Agents Chemother; 1999 Jul 12; 43(7):1747-53. PubMed ID: 10390234
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. I. Synergistic actions of cefotiam with imipenem and vancomycin].
    Deguchi K, Yokota N, Koguchi M, Suzuki Y, Suzuki K, Fukayama S, Ishihara R.
    Jpn J Antibiot; 1993 Feb 12; 46(2):115-22. PubMed ID: 8331771
    [Abstract] [Full Text] [Related]

  • 20. Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus.
    Tabuchi F, Matsumoto Y, Ishii M, Tatsuno K, Okazaki M, Sato T, Moriya K, Sekimizu K.
    J Antibiot (Tokyo); 2017 Jun 12; 70(6):771-774. PubMed ID: 28196977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.